Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has shared an announcement.
Wai Chun Bio-Technology Limited has announced a delay in the dispatch of a circular related to a connected transaction involving the issuance of new convertible bonds under a specific mandate. The circular, initially expected to be sent to shareholders by May 13, 2025, will now be dispatched by May 30, 2025, due to the need for additional time to finalize certain information. This delay could impact the timeline of the proposed transaction and may affect stakeholders’ planning and decision-making processes.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a company incorporated in the Cayman Islands, operating within the biotechnology industry. It is listed on the Stock Exchange of Hong Kong and focuses on biotechnology-related products and services.
Average Trading Volume: 239,924
Technical Sentiment Signal: Hold
Current Market Cap: HK$24.63M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.